Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
276.62B | 266.81B | 251.57B | 215.88B | 193.40B | 226.42B | Gross Profit |
80.82B | 75.39B | 71.25B | 62.74B | 47.63B | 60.27B | EBIT |
22.78B | 21.26B | 18.98B | 17.84B | 8.90B | 16.15B | EBITDA |
35.16B | 40.28B | 32.74B | 30.82B | 21.86B | 29.07B | Net Income Common Stockholders |
21.54B | 18.55B | 13.74B | 14.54B | 8.71B | 11.58B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
62.98B | 77.92B | 59.58B | 55.44B | 48.06B | 32.98B | Total Assets |
375.65B | 391.30B | 345.88B | 332.62B | 307.33B | 294.10B | Total Debt |
27.77B | 30.86B | 35.62B | 39.23B | 42.20B | 42.46B | Net Debt |
-30.62B | -46.46B | -21.29B | -9.88B | 334.00M | 13.45B | Total Liabilities |
116.56B | 130.74B | 119.30B | 122.86B | 119.84B | 118.04B | Stockholders Equity |
256.87B | 258.40B | 224.40B | 207.75B | 185.79B | 174.36B |
Cash Flow | Free Cash Flow | ||||
3.61B | 27.74B | 12.43B | 13.00B | 18.17B | 5.61B | Operating Cash Flow |
12.33B | 38.58B | 21.35B | 21.00B | 27.89B | 20.27B | Investing Cash Flow |
-8.92B | -9.16B | -9.28B | -9.07B | -9.56B | -14.24B | Financing Cash Flow |
-21.35B | -15.70B | -9.96B | -7.78B | -4.35B | -10.38B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
€1.15B | 8.62 | 8.48% | 4.41% | ― | ― | ||
66 Neutral | $4.50B | 12.29 | 5.40% | 248.66% | 4.13% | -12.33% | |
$1.96B | 14.95 | 6.35% | 1.98% | ― | ― | ||
€1.32B | 11.73 | 14.03% | 2.61% | ― | ― | ||
74 Outperform | ¥240.45B | 19.89 | 1.35% | 16.07% | 61.09% | ||
69 Neutral | ¥96.67B | 10.93 | 5.31% | 7.73% | 27.91% | ||
68 Neutral | ¥126.31B | 9.86 | 2.47% | 12.12% | 5.56% |